KEANE WILLIAM P 4
4 · SALIX PHARMACEUTICALS LTD · Filed Apr 9, 2012
Insider Transaction Report
Form 4
KEANE WILLIAM P
Director
Transactions
- Award
Common Stock
2012-04-05+4,160→ 43,202 total
Holdings
- 30,000
Option to Buy Common Stock
Exercise: $15.25Exp: 2014-01-14→ Common Stock (30,000 underlying) - 22,500
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (22,500 underlying) - 15,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]Represents a restricted stock award which vests in its entirety on the earlier of July 1, 2013 or immediately prior to the 2013 Annual Stockholder meeting, subject to continued service as a director.
- [F2]Options are 100% vested.